Processing Your Payment
Please do not leave this page until complete. This can take a few moments.
Your search found 63 results
-
February 12, 2018 -Holliston biotech Biostage has appointed another medical professional to its scientific advisory board as the company continues its makeover following a near bankruptcy position just months ago.
February 12, 2018 -Holliston biotech Biostage has appointed another medical professional to its scientific advisory board as the company continues its makeover following a near bankruptcy position just months ago.
February 9, 2018 -Holliston biotech Biostage has secured another investment, $1 million from a private investor named Jinhui Liu.
February 9, 2018 -Holliston biotech Biostage has secured another investment, $1 million from a private investor named Jinhui Liu.
February 8, 2018 -A Chinese investor and biotech executive has been appointed to be chairman of Holliston-based Biostage's board of directors.
February 8, 2018 -A Chinese investor and biotech executive has been appointed to be chairman of Holliston-based Biostage's board of directors.
January 31, 2018 -Holliston biotech has appointed a Connecticut children's hospital doctor to its scientific advisory board less than a month after the company closed on a $100,000 investment from the same hospital.
January 31, 2018 -Holliston biotech has appointed a Connecticut children's hospital doctor to its scientific advisory board less than a month after the company closed on a $100,000 investment from the same hospital.
January 23, 2018 -What's it like to bring a company back to life after near bankruptcy? Jim McGorry, CEO of Holliston biotech Biostage, explains how the company never lost faith.
January 23, 2018 -What's it like to bring a company back to life after near bankruptcy? Jim McGorry, CEO of Holliston biotech Biostage, explains how the company never lost faith.
January 3, 2018 -Holliston-based Biostage announced Wednesday the closing of a $4.2-million private investment primarily with a Chinese investment group and a Connecticut children's hospital.
January 3, 2018 -Holliston-based Biostage announced Wednesday the closing of a $4.2-million private investment primarily with a Chinese investment group and a Connecticut children's hospital.
December 27, 2017 -In order to complete a $4-million deal with a private investor and save the company from insolvency, Holliston biotech Biostage has performed a 20:1 reverse stock split.
December 27, 2017 -In order to complete a $4-million deal with a private investor and save the company from insolvency, Holliston biotech Biostage has performed a 20:1 reverse stock split.
December 14, 2017 -Two months after laying off more than 70 percent of its workforce and being delisted from Nasdaq, Holliston biotech Biostage announced on Thursday a $4-million private investment.
December 14, 2017 -Two months after laying off more than 70 percent of its workforce and being delisted from Nasdaq, Holliston biotech Biostage announced on Thursday a $4-million private investment.
December 7, 2017 -Holliston biotech Biostage will officially be delisted on Dec. 18 from the Nasdaq Stock Excahnge, after failing to keep a high enough stock price.
December 7, 2017 -Holliston biotech Biostage will officially be delisted on Dec. 18 from the Nasdaq Stock Excahnge, after failing to keep a high enough stock price.
November 15, 2017 -Hollistion biotech manufacturer Biostage has notified the U.S. Securities and Exchange Commission its third-quarter report will be late.
November 15, 2017 -Hollistion biotech manufacturer Biostage has notified the U.S. Securities and Exchange Commission its third-quarter report will be late.
October 13, 2017 -After being delisted on NASDAQ last week, Holliston biotech Biostage has laid off 17 of its 24 employees, a 71-percent reduction, the company announced Thursday.
October 13, 2017 -After being delisted on NASDAQ last week, Holliston biotech Biostage has laid off 17 of its 24 employees, a 71-percent reduction, the company announced Thursday.
October 10, 2017 -Holliston biotechnology firm Biostage, Inc. was delisted from the NASDAQ on Friday because its stock price was too low.
October 10, 2017 -Holliston biotechnology firm Biostage, Inc. was delisted from the NASDAQ on Friday because its stock price was too low.
August 9, 2017 -Holliston-based Biostage Inc. on Monday announced the first implant of its proprietary Cellspan Esophageal Implant in a human patient.
August 9, 2017 -Holliston-based Biostage Inc. on Monday announced the first implant of its proprietary Cellspan Esophageal Implant in a human patient.
June 27, 2017 -Biostage, Inc. of Holliston has enough funding to get it through the end of 2018, following a stock purchase worth $3.1 million by one of its investors.
June 27, 2017 -Biostage, Inc. of Holliston has enough funding to get it through the end of 2018, following a stock purchase worth $3.1 million by one of its investors.
June 12, 2017 -With the threat of NASDAQ delisting looming, executives at Holliston-based Biostage Inc. are looking for new ways to finance the continued development of its regenerative platform.
June 12, 2017 -With the threat of NASDAQ delisting looming, executives at Holliston-based Biostage Inc. are looking for new ways to finance the continued development of its regenerative platform.
